Over the years, Metropolis has built a strong foundation in advanced genomics, with a particular focus on precision oncology anchored by its Global Reference Laboratory in Mumbai. Following the ...

BOSTON, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Precede Biosciences, a precision diagnostics and data company focused on enabling the next generation of precision medicines, today announced that it has ...

All-share acquisition positions Inspira to expand into a multi-billion dollar diagnostics market with a development-ready innovative technology; transaction structured to include significant protectio ...

Today, the conflict in Sudan reaches its 1000th day, with over 20 million people requiring health assistance and 21 million ...

Adaptive Biotechnologies plans to release its complete fourth quarter and full year 2025 financial results during its earnings call in February 2026. 1 Excludes Digital Biotechnologies, Inc. cash and ...

Tal Parnes, Chairman of the Board of Inspira Technologies, stated: “The contemplated acquisition of this liquid biopsy platform represents a significant value inflection point for Inspira, adding a ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first ...

MEXC , the fastest-growing global cryptocurrency exchange, redefining a user-first approach to digital assets through true ...

That experience moved Hurley to seek out PrEP, shorthand for preexposure prophylaxis. The antiretroviral medication greatly ...

Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave ...

Some insurance creates perverse incentives that discourage patients from seeking care — sometimes turning minor, treatable ...